Candel Therapeutics Shares Tumble 39% After-Hours: Here's Why
Published . Updated .
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
This report does not map to a usual set of affected companies.
Directly affected
- CADL Candel Therapeutics
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Candel Therapeutics belongs to, so it often moves with news about it.
- AMGN Amgen+14.9% 30d
Amgen is a peer of Candel Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
- GILD Gilead Sciences+17.7% 30d
Gilead Sciences is a peer of Candel Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
- MRNA Moderna+29.2% 30d
Moderna is a peer of Candel Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
- ARGX argenx SE-11.9% 9d
argenx SE is a peer of Candel Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
- RVMD Revolution Medicines
Revolution Medicines is a peer of Candel Therapeutics in biological products, (no diagnostic substances); rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| CADL | +4.29% | +11.32% | base | after close | after close | after close | after close |
| XLV | -1.60% | +0.57% | base | after close | after close | after close | after close |
| AMGN | -1.47% | -0.45% | base | after close | after close | after close | after close |
| GILD | -0.65% | +1.72% | base | after close | after close | after close | after close |
| MRNA | +10.00% | +8.35% | base | after close | after close | after close | after close |
| ARGX | -5.30% | -0.83% | base | after close | after close | after close | after close |
| RVMD | +9.06% | +9.53% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Candel Therapeutics Shares Tumble 39% After-Hours: Here's Why Benzinga
Source: Benzinga
This story
| Company | When | Move | Status |
|---|---|---|---|
| AMGN | three days earlier | -0.45% | final price |
| AMGN | five days earlier | -1.47% | final price |
| ARGX | three days earlier | -0.83% | final price |
| ARGX | five days earlier | -5.30% | final price |
| CADL | three days earlier | +11.32% | final price |
| CADL | five days earlier | +4.29% | final price |
| GILD | three days earlier | +1.72% | final price |
| GILD | five days earlier | -0.65% | final price |
| MRNA | three days earlier | +8.35% | final price |
| MRNA | five days earlier | +10.00% | final price |
| RVMD | three days earlier | +9.53% | final price |
| RVMD | five days earlier | +9.06% | final price |
| XLV | three days earlier | +0.57% | final price |
| XLV | five days earlier | -1.60% | final price |
Trades by members of Congress and officials in the stocks in this story
- Sen. Sheldon Whitehouse sold Amgen (AMGN) (held by a spouse), worth $15,001 - $50,000 on 15 Oct 2026. That is 29 days before publication. Filed 2 Nov 2026. View the filing.
- Rep. David J. Taylor bought Amgen (AMGN), worth $1,001 - $15,000 on 22 Sep 2026. That is 52 days before publication. Filed 1 Oct 2026. View the filing.
- Rep. David J. Taylor sold Amgen (AMGN), worth $1,001 - $15,000 on 26 Aug 2026. That is 79 days before publication. Filed 5 Sep 2026. View the filing.
- Rep. Maria Elvira Salazar sold Moderna (MRNA), worth $1,001 - $15,000 on 24 Sep 2026. That is 50 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Moderna (MRNA) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 70 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Moderna (MRNA), worth $1,001 - $15,000 on 28 Aug 2026. That is 77 days before publication. Filed 8 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100
“Candel Therapeutics Shares Tumble 39% After-Hours: Here's Why” scores 12 out of 100. The score uses 1 sources.